InCube Labs and Teijin Limited Announce Strategic Partnership to Accelerate Healthcare Innovation

 InCube Labs and Teijin Limited Announce Strategic Partnership to Accelerate
                            Healthcare Innovation

PR Newswire

SAN JOSE, Calif., Jan. 8, 2013

SAN JOSE, Calif., Jan. 8, 2013 /PRNewswire/ -- InCube Labs, a life sciences
research lab focused on developing medical breakthroughs that dramatically
improve patient outcomes, today announced that it has entered into a strategic
partnership with Teijin Limited, a worldwide leader in technology innovation.
Headquartered in Japan and with around 150 companies and 17,000 employees in
over 20 countries worldwide, Teijin will have regular access to InCube Labs'
leadership team to help define new strategic growth opportunities for Teijin's
healthcare business.

As part of the agreement, Teijin will also invest in InCube Ventures, InCube's
life sciences venture fund. Through its strategic investment in InCube
Ventures, Teijin will have access to InCube's network, portfolio companies and
partners.

"Our objective was to find a US partner that deeply understands the market
including the technology and business opportunities in healthcare," said Kazuo
Imose, Teijin Group Corporate Officer & General Manager, New Business
Incubation & Development Division. "We have been extremely impressed with
InCube Labs' deep domain knowledge and impressive track record of healthcare
innovation and company formation. We are confident that Mir Imran and the
InCube Labs team will provide tremendous value as we assess opportunities in
the healthcare space. We are proudto participate in InCube Labs' network."

"Teijin has a long history of innovation which to date has centered on its
novel materials from polyesters and aramids to polycarbonates. The company has
been expanding beyond its materials business, and now is pursuing a range of
additional market opportunities including healthcare," said Mir Imran,
Chairman & CEO, InCube Labs. "We are in a strong position to help Teijin
identify and pursue the most promising and strategic new healthcare
opportunities to grow Teijin's business."

Teijin has declared healthcare as one of its most promising growth
businesses. In Fiscal 2011, healthcare – including pharmaceuticals and home
healthcare – accounted for 18% of Teijin's business. Teijin aims to further
expand the business by creating new solutions based on materials and
healthcare technologies. 

About InCube Labs
Based in Silicon Valley and San Antonio, InCube Labs is a life sciences
research lab focused on developing medical breakthroughs that dramatically
improve patient outcomes. Our multi-disciplinary approach integrates
traditional device technologies such aselectronics, software, mechanical
engineering and material science, with innovations from the pharmaceutical
industry, often involving protein chemistry, pharmacology and cell biology.
InCube is led by Mir Imran, an accomplished medical innovator, entrepreneur
and venture capitalist, who has founded more than 20 life sciences companies
and holds more than 200 patents. Many of Imran's innovations have resulted in
new standards of care, including the first FDA-approved Automatic Implantable
Cardioverter Defibrillator.For more information, please go
towww.incubelabs.com.

About the Teijin Group
Teijin (TSE 3401) is a technology-driven global group offering advanced
solutions in the areas of sustainable transportation, information and
electronics, safety and protection, environment and energy, and healthcare.
Its main fields of operation are high-performance fibers such as aramid,
carbon fibers & composites, healthcare, films, resin & plastic processing,
polyester fibers, products converting and IT. The group has some 150 companies
and around 17,000 employees spread out over 20 countries worldwide. It posted
consolidated sales of JPY 854.4 billion (USD 10.7 billion) and total assets of
JPY 762.1 billion (USD 9.5 billion) in the fiscal year ending March 31, 2012.
For more information, please go to www.teijin.co.jp.

SOURCE InCube Labs

Website: http://www.incubelabs.com
Contact: Stephanie McGrory, Vice President, Business Development,
+1-408-457-3730, stephanie@incubelabs.com
 
Press spacebar to pause and continue. Press esc to stop.